Literature DB >> 3668739

Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study.

K Tatara1, S Kusakawa.   

Abstract

The incidence of coronary obstruction subsequent to giant coronary aneurysm in Kawasaki disease was studied. In 20 cases, aneurysms with a maximal diameter greater than 8 mm were identified by coronary angiography 2 to 120 months (mean 16.9 months) after onset. There were 25 giant aneurysms among these 20 patients, all of whom underwent coronary angiography between 12 and 134 months (mean 31.7 months) after initial examination. Coronary obstruction occurred in six cases (30.0%), all within 4 years of onset of disease. There were five obstructive aneurysms in the right coronary artery (5/12; 41.7%) and two in the left coronary artery (2/13; 15.4%). One of these patients developed symptomatic myocardial infarction. Two had abnormal electrocardiographic findings suggesting myocardial infarction. In five cases, persistent perfusion defects were found by myocardial imaging. On the other hand, in two patients giant aneurysms persisted without obstructive changes for greater than 10 years. In both cases the aneurysm was in the left coronary artery and obstruction of the right coronary artery was found at initial angiography. These results seem to indicate the limited efficacy of antiplatelet therapy for giant coronary aneurysms in Kawasaki disease and that giant aneurysms are likely to progress to become obstructive within a few years even if antiplatelet therapy is given. Other forms of treatment, including surgery, should therefore be considered in such patients.

Entities:  

Mesh:

Year:  1987        PMID: 3668739     DOI: 10.1016/s0022-3476(87)80246-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease.

Authors:  E Tsuda; T Kamiya; Y Ono; K Kimura; K Kurosaki; S Echigo
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

2.  Midterm outcome of percutaneous transcatheter coil occlusion of coronary artery fistula.

Authors:  Chi-D Liang; Sheung F Ko
Journal:  Pediatr Cardiol       Date:  2006-08-30       Impact factor: 1.655

Review 3.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  Kawasaki disease: an update.

Authors:  G K Singh
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

5.  Occult Kawasaki syndrome with giant coronary artery aneurysms.

Authors:  R M Hinson; T D Schofield; J French; J G Stevenson; D Stewart; J B Kinney
Journal:  West J Med       Date:  1993-02

6.  Coronary arterial lesions due to Kawasaki disease: selective coronary angiography in five cases with difficult-to-detect localized stenosis.

Authors:  S Tsubata; A Suzuki; Y Ono; T Kamiya; I Hashimoto; A Miyazaki; F Ichida; T Okada
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

7.  Coronary artery calcification in Kawasaki disease.

Authors:  T Ino; S Shimazaki; K Akimoto; I Park; K Nishimoto; K Yabuta; A Tanaka
Journal:  Pediatr Radiol       Date:  1990

Review 8.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

9.  Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions.

Authors:  Fabienne Mueller; Walter Knirsch; Paul Harpes; René Prêtre; Emanuela Valsangiacomo Buechel; Oliver Kretschmar
Journal:  Clin Res Cardiol       Date:  2009-06-05       Impact factor: 5.460

Review 10.  Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance.

Authors:  Song Soo Kim; Sung Min Ko; Sang Il Choi; Bo Hwa Choi; Arthur E Stillman
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.